C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2586275
The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukaemia and to a method for identifying therapeutic agents or the efficient combination thereof for inducing the differentiation of myelogenous leukaemia cells.
L'invention a pour objet l'utilisation d'une molécule d'acides nucléiques dérivée d'un miRNA pour fabriquer un médicament destiné au traitement de la leucémie myéloïde et un procédé pour identifier des agents thérapeutiques ou des combinaisons d'agents thérapeutiques efficaces pour induire la différenciation de cellules issues d'une leucémie myéloïde.
Lanotte Michel
Lecellier Charles-Henri
Saumet Anne
Voinnet Olivier
Centre National de La Recherche Scientifique - Cnrs
Smart & Biggar
LandOfFree
Identification and use of mirnas for differentiating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification and use of mirnas for differentiating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification and use of mirnas for differentiating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2067788